Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan for exercise capacity in Eisenmenger syndrome (Phase 3)
2012-003335-33Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in Eisenmenger syndrome, sponsored by Actelion Pharmaceuticals Ltd. Started Nov 2012; status: completed.
02
Drugs
macitentan
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on 2012-003335-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003335-33.